LEADER 01880oam 2200505 450 001 9910707190903321 005 20180906095630.0 035 $a(CKB)5470000002461585 035 $a(OCoLC)946637956 035 $a(EXLCZ)995470000002461585 100 $a20160414d2016 ua 0 101 0 $aeng 135 $aurbn||||a|||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aFAA reauthorization $eaviation safety and general aviation : hearing before the Subcommittee on Aviation Operations, Safety, and Security of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Fourteenth Congress, first session, April 28, 2015 210 1$aWashington :$cU.S. Government Publishing Office,$d2016. 215 $a1 online resource (iii, 87 pages) $cillustrations 225 1 $aS. hrg. ;$v114-226 300 $aTitle from title screen (viewed on Apr. 14, 2016). 300 $aPaper version available for sale by the Superintendent of Documents, United States Government Publishing Office. 320 $aIncludes bibliographical references. 517 $aFAA reauthorization 606 $aAeronautics$zUnited States$xSafety measures$xFinance 606 $aPrivate flying$zUnited States$xSafety measures$xFinance 606 $aFederal aid to transportation$zUnited States 608 $aLegislative hearings.$2lcgft 615 0$aAeronautics$xSafety measures$xFinance. 615 0$aPrivate flying$xSafety measures$xFinance. 615 0$aFederal aid to transportation 801 0$bGPO 801 1$bGPO 801 2$bGPO 801 2$bSTF 801 2$bOCLCO 801 2$bOCLCA 801 2$bLWA 801 2$bOCLCF 801 2$bUOK 801 2$bGPO 906 $aBOOK 912 $a9910707190903321 996 $aFAA reauthorization$93436726 997 $aUNINA LEADER 05403nam 2201405 a 450 001 9910790953203321 005 20230126205336.0 010 $a1-4008-4041-4 010 $a9786613290939 010 $a1-283-29093-6 024 7 $a10.1515/9781400840410 035 $a(CKB)2550000001252140 035 $a(EBL)784516 035 $a(OCoLC)758374143 035 $a(SSID)ssj0000536219 035 $a(PQKBManifestationID)11346962 035 $a(PQKBTitleCode)TC0000536219 035 $a(PQKBWorkID)10546606 035 $a(PQKB)11039704 035 $a(MiAaPQ)EBC784516 035 $a(StDuBDS)EDZ0000515055 035 $a(MdBmJHUP)muse37047 035 $a(DE-B1597)447680 035 $a(OCoLC)979779984 035 $a(DE-B1597)9781400840410 035 $a(Au-PeEL)EBL784516 035 $a(CaPaEBR)ebr10503237 035 $a(CaONFJC)MIL329093 035 $a(EXLCZ)992550000001252140 100 $a20110425d2011 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 14$aThe enculturated gene$b[electronic resource] $esickle cell health politics and biological difference in West Africa /$fDuana Fullwiley 205 $aCourse Book 210 $aPrinceton, N.J. $cPrinceton University Press$d2011 215 $a1 online resource (727 p.) 300 $aDescription based upon print version of record. 311 $a0-691-12317-9 311 $a0-691-12316-0 320 $aIncludes bibliographical references and index. 327 $aIntroduction: the powers of association -- Healthy sicklers with "mild" disease: local illness affects and population-level effects -- The biosocial politics of plants and people -- Attitudes of care -- Localized biologies: mapping race and sickle cell difference in French West Africa -- Ordering illness: heterozygous "trait" suffering in the land of the mild disease -- The work of patient advocacy -- Conclusion: economic and health futures amid hope and despair. 330 $aIn the 1980's, a research team led by Parisian scientists identified several unique DNA sequences, or haplotypes, linked to sickle cell anemia in African populations. After casual observations of how patients managed this painful blood disorder, the researchers in question postulated that the Senegalese type was less severe. The Enculturated Gene traces how this genetic discourse has blotted from view the roles that Senegalese patients and doctors have played in making sickle cell ""mild"" in a social setting where public health priorities and economic austerity programs have forced people to 606 $aSickle cell anemia$xSocial aspects$zSenegal 606 $aSickle cell anemia$xGenetic aspects 606 $aSickle cell anemia$xPatients$xServices for$zSenegal 606 $aGenetic disorders$xSocial aspects$zSenegal 606 $aKinship$xHealth aspects$zSenegal 610 $aAfrica. 610 $aAfrican anthropology. 610 $aAfrican genetics. 610 $aAfrican sicklers. 610 $aAlbert Royer Children's Hospital. 610 $aCNTS. 610 $aCentre nationale de transfusion sanguine. 610 $aDNA haplotypes. 610 $aDNA sequences. 610 $aHbAS. 610 $aInternational Organization for the Fight against Sickle Cell. 610 $aNational Blood Transfusion Center. 610 $aOILD. 610 $aRFLP. 610 $aRestriction Fragment Length Polymorphism. 610 $aSenegal. 610 $aSenegalese attitudes. 610 $aSenegalese sickle cell. 610 $aalternative care. 610 $abiological expressions. 610 $abiosocial politics. 610 $aculture. 610 $adisease experiences. 610 $adisease expression. 610 $aeconomic austerity. 610 $aeconomically triaged care. 610 $aethnic population purity. 610 $afagara. 610 $agenetic difference. 610 $agenetic sequence. 610 $ageneticists. 610 $aglobal health problems. 610 $aglobal health. 610 $ahealing practices. 610 $ahealth intervention. 610 $ahealth. 610 $ahealthy sicklers. 610 $aheterozygous sickle cell. 610 $alow-tech strategy. 610 $amultilateral institutions. 610 $anormalization techniques. 610 $apatient advocacy. 610 $apolitical apathy. 610 $apopulation. 610 $apublic health. 610 $apublic neglect. 610 $aself-care. 610 $asickle cell DNA markers. 610 $asickle cell anemia. 610 $asickle cell gene. 610 $asickle cell research. 610 $asickle cell trait. 610 $asicklers. 610 $asocial networks. 610 $atraditional plants. 610 $avitality. 615 0$aSickle cell anemia$xSocial aspects 615 0$aSickle cell anemia$xGenetic aspects. 615 0$aSickle cell anemia$xPatients$xServices for 615 0$aGenetic disorders$xSocial aspects 615 0$aKinship$xHealth aspects 676 $a362.196/15271009663 700 $aFullwiley$b Duana$01465353 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910790953203321 996 $aThe enculturated gene$93675338 997 $aUNINA